L
Liang-In Lin
Researcher at National Taiwan University
Publications - 107
Citations - 5398
Liang-In Lin is an academic researcher from National Taiwan University. The author has contributed to research in topics: Myeloid leukemia & Leukemia. The author has an hindex of 34, co-authored 105 publications receiving 4752 citations.
Papers
More filters
Journal ArticleDOI
Stability of curcumin in buffer solutions and characterization of its degradation products
Ying-Jan Wang,Min-Hsiung Pan,Ann-Lii Cheng,Liang-In Lin,Yuan Soon Ho,Chang-Yao Hsieh,Jen-Kun Lin +6 more
TL;DR: It was shown that decomposition was pH-dependent and occurred faster at neutral-basic conditions and vanillin, ferulic acid, feruloyl methane were identified as minor degradation products and the amount of vanillin increased with incubation time.
Journal ArticleDOI
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.
Jih-Luh Tang,Hsin-An Hou,Chien-Yuan Chen,Chieh-Yu Liu,Wen-Chien Chou,Mei-Hsuan Tseng,Chi-Fei Huang,Fen-Yu Lee,Ming-Chih Liu,Ming Yao,Shang-Yi Huang,Bor-Sheng Ko,Szu-Chun Hsu,Shang-Ju Wu,Woei Tsay,Yao-Chang Chen,Liang-In Lin,Hwei-Fang Tien +17 more
TL;DR: It is demonstrated that RUNX1 mutation was an independent poor prognostic factor for overall survival and associated with distinct biologic and clinical characteristics and poor prognosis in patients with de novo AML.
Journal ArticleDOI
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
Hsin-An Hou,Yuan-Yeh Kuo,Chieh-Yu Liu,Wen-Chien Chou,Ming Cheng Lee,Chien-Yuan Chen,Liang-In Lin,Mei-Hsuan Tseng,Chi-Fei Huang,Ying-Chieh Chiang,Fen-Yu Lee,Ming-Chih Liu,Chia-Wen Liu,Jih-Luh Tang,Ming Yao,Shang-Yi Huang,Bor-Sheng Ko,Szu-Chun Hsu,Shang-Ju Wu,Woei Tsay,Yao-Chang Chen,Hwei-Fang Tien +21 more
TL;DR: The DNMT3A mutation may be a potential biomarker for monitoring of minimal residual disease and an independent poor prognostic factor for overall survival and relapse-free survival in total patients and also in normokaryotype group.
Journal ArticleDOI
Characterization of CEBPA Mutations in Acute Myeloid Leukemia: Most Patients with CEBPA Mutations Have Biallelic Mutations and Show a Distinct Immunophenotype of the Leukemic Cells
Liang-In Lin,Chien-Yuan Chen,Dong-Tsamn Lin,Woei Tsay,Jih-Luh Tang,You-Chia Yeh,Hwei-Ling Shen,Fang-Hsien Su,Ming Yao,Sheng-Yi Huang,Hwei-Fang Tien +10 more
TL;DR: Most AML with CEBPA mutations were associated with an immunophenotype of HLA-DR+CD7+CD13+CD14−CD15+CD33+CD34+, which implicate theCEBPA mutation as a potential marker for monitoring minimal residue disease.
Journal ArticleDOI
Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution.
Wen-Chien Chou,Jih-Luh Tang,Liang-In Lin,Ming Yao,Woei Tsay,Chien-Yuan Chen,Shang-Ju Wu,Chi-Fei Huang,Rong-Jing Chiou,Mei-Hsuan Tseng,Dong-Tsamn Lin,Kai-Hsin Lin,Yao-Chang Chen,Hwei-Fang Tien +13 more
TL;DR: The findings that NPM mutations are stable during disease evolution and closely associated with disease status make it a potential marker for monitoring minimal residual disease.